But if the stock market finishes this month with another advance, TJM's Jim Iuorio tells CNBC he's ready to throw in the towel on his correction call for now.» Read More
Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell. Today Cramer is keeping an eye on shares of AT&T and DirectTV after rumors surfaced "Ma Bell" was nearing a bid for the DirectTV.
Ann Winblad, Hummer Winblad Venture Partners, shares her top technology plays
Walter Piecyk and Rich Greenfield, BTIG, share their thoughts on reports AT&T may make a nearly $50 billion bid for DirecTV.
CNBC's Rick Santelli breaks down the latest numbers on consumer spending and trade.
Not every management is doing a good job, says Paul Roth, Schulte Roth & Zabel LLP partner, sharing his thoughts on shareholder activism in the boardroom.
Brian Singer, William Blair, shares his outlook on the markets and where he sees the best investment opportunities.
CNBC's Meg Tirrell reports the latest details on U.S. drug maker Pfizer's bid to buy AstraZeneca.
Peter Skibitski, Drexel Hamilton defense analyst, shares his thoughts on the future of the defense industry.
From drones to robot armies, CNBC's Jane Wells takes a look at what the U.S. defense industry might look like in 25 years.
CNBC's Steve Liesman and Bill Dunkelberg, National Federation of Independent Business, break down the latest data on small business.
Sean Connolly, President & Chief Executive Officer of Hillshire Brands, discusses his company's plans to acquire Pinnacle Foods and explains how the deal will create a leading branded food company
Oscar Schafer, Rivulet Capital chairman, shares his thoughts on the M&A space and investing in a low-growth environment.
AT&T is in active talks to buy satellite-TV provider DirecTV and may complete a deal in the next few weeks, according to media reports.
CNBC's Meg Tirrell reports the latest details on U.S. drugmaker Pfizer's bid to buy AstrZeneca.
David Krantz, YP CEO, explains how company is transforming itself for the mobile age.
David Blitzer, S&P Dow Jones Indices, and Maury Harris, UBS Investment Research, share their thoughts on market valuations and whether to expect a correction in the markets.
CNBC's Julia Chatterly reports on all the market moving events from Europe, as shares move higher following record highs on the Dow and S&P 500 in the U.S.
Barbara Ryan, FTI Consulting, weighs in on Pfizer's bid to acquire AstraZeneca, and what's driving consolidation in the pharma space.
Pfizer CEO Ian speaks before British lawmakers on his company's bid for AstraZeneca, reports CNBC's Meg Tirrell.
Stocks rally as momentum stocks stabilize, bonds rise across the globe and China and India see strong gains.
Get the best of CNBC in your inbox